Raia Drogasil inscreases profits by 33% in 3Q16
Lucro da Raia Drogasil sobe 33% no 3º Trimestre de 2016
Intel ID : 242040
| Synopsis |
|
Raia Drogasil (BVMF: RADL3), a Sao Paulo drugstore chain registered a profit of BRL 127m in Q316, an increase of 33% over the same period of 2015, according a company press release published on 27 October, 2016. The gross income reached BRL 3,05bn, an increase of 25.2% year over year . Gross margin was 29.5%, up 0.9% on annual basis.
(content in portuguese)
A Raia Drogasil (BVMF:RADL3), rede de drogarias sediada em São Paulo, teve lucro líquido ajustado de BRL 127m no 3º Trimestre de 2016, o que representa um incremento de 33% em relação ao mesmo período de 2015, segundo publicou a empresa em Comunicado no dia 27 de outubro de 2016. Segundo o comunicado, a receita bruta da empresa alcançou BRL 3,05bi, com acréscimo ano a ano de 25,2%. A margem bruta ficou em 29,5%, alta de 0,9% na base anual. |
Relevant Documents
| Company Report | 27 Oct 2016 | Raia_Drogasil_Divulgacao_de_Resultados_2016.pdf | PT |
|
| Intel ID | 242040 | |
| Value | ND | |
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
|
|
Financial Data - Raia Drogasil
(31 Dec 2024) |
Revenue: EUR 6.068,27m EBITDA: EUR 656,29m Net Debt: EUR 429,34m Exchange Rate: 
|
|
| Date |
|
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
15.05.05 Drug Stores & Pharmacies 15 Consumer Products & Services / 15.05 Distribution & Retail |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.